Catalyst Wire Dossier Catalyst Wire Dossier

DFD-29 capsules

DFD-29 · Journey Medical Corporation
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DFD-29 capsules, covering 2024-12-03 to 2024-12-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) [Phase 3]

See pricing